Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Prospective Study Evaluating the Interest of HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding

NCT04867109 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT04867109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04867109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Prospective Study Evaluating the Interest of HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 25, 2021
Completion date
September 1, 2022
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ca 125 antigen, cancer biomarker, endometrial neoplasms, postmenopause, uterine hemorrhage